Put Buying in AstraZeneca (AZN) Suggests Near-Term Bearish Bias in Shares -Susquehanna

Susquehanna options strategist Alison Edwards notes near-term bearish bias in AstraZeneca (NYSE: AZN), as investors purchased about 3000 Aug 28.5 Puts and 6,000 Aug 30 Puts.

You May Also Be Interested In

• Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NS
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
• Meta's Zuckerberg Says Ai Agent Tech Progressing Slower Than Expected - Reuters